Oral News and Research

RSS

SCYNEXIS announces positive results from first interim efficacy analysis of FURI study

SCYNEXIS, Inc., a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced positive results from the first interim efficacy analysis of the ongoing FURI study.

1 Feb 2019

Microbes on the tongue could be used to diagnose pancreatic cancer

Researchers have found that disruption in the microbial composition of the tongue coating could serve as a biomarker for early-stage pancreatic cancer.

31 Jan 2019

New drug for sleeping sickness approved in the Democratic Republic of Congo

Marketing authorization of fexinidazole for the treatment of Trypanosoma brucei gambiense human African trypanosomiasis (HAT), more commonly known as sleeping sickness, has been granted in the Democratic Republic of Congo (DRC).

31 Jan 2019

OHS pipeline program enhance academic preparedness of students from minority groups

Boston University's Oral Health Sciences master's program is a successful credential-enhancing program for dental school applicants, while also serving as a pipeline to increase the number of qualified applicants from underrepresented minority groups.

30 Jan 2019

Vaccination with live S. mitis may offer protection from Streptococcus pneumoniae

Vaccinating laboratory mice with Streptococcus mitis bacteria prevents their virulent sibling, Streptococcus pneumoniae from infecting the mice.

30 Jan 2019

FDA approves first generic version of commonly prescribed asthma inhaler

The U.S. Food and Drug Administration today approved the first generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for the twice-daily treatment of asthma in patients aged four years and older and maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease.

30 Jan 2019

POWTECH 2019: Innovations to provide more speed, efficiency in pharmaceutical production

At POWTECH 2019 from 9 to 11 April in Nuremberg, trade visitors will experience the entire range of innovations in mechanical processing technology.

From POWTECH 24 Jan 2019

Researchers demonstrate strong evidence connecting bacterial pathogen and Alzheimer's pathogenesisis

New science uncovers how an unlikely culprit, Porphyromonas gingivalis (Pg) - the bacterium commonly associated with chronic gum disease - appears to drive Alzheimer's disease (AD) pathology.

24 Jan 2019

Opioid overdose patients can be safely discharged an hour after administration of naloxone

Suspected opioid overdose patients treated with naloxone are safe for discharge from the emergency department after one hour.

23 Jan 2019

The connection between the Pope and contraceptive pills

Millions of women around the world use the combined hormonal oral contraceptive pill whcih has been around the past six decades. The usual method advised is a 21 day cycle of the pill followed by a 7 day break when the woman bleeds.

22 Jan 2019

Study to investigate new targeted oral treatments for severe asthma

A £2.68 million study to investigate the effective use of antibiotics to treat certain types of severe asthma is being spearheaded by researchers in Leicester.

21 Jan 2019

Orthodontic treatment does not guarantee future dental health

A commonly held belief among the general public is orthodontic treatment will prevent future tooth decay. Research undertaken at the University of Adelaide has found that this is not the case.

21 Jan 2019

Specific cognitive deficits found in individuals with spinal cord injury

A multidisciplinary team of researchers has identified specific cognitive deficits in individuals with spinal cord injury. Their findings support the theory of accelerated aging after SCI, and have important implications for further research.

21 Jan 2019

ACCC survey finds multiple threats to growth of cancer programs

At a time of unprecedented advances in the science of cancer, growing complexity in cancer treatments, and ongoing health policy fluctuation, the Association of Community Cancer Centers ninth annual Trending Now in Cancer Care survey reveals how cancer programs across the country are being impacted by pressure from turbulence in multiple sectors: payers, government, and industry.

18 Jan 2019

Combination therapy shows high efficacy in treating people with leishmaniasis and HIV

The results of clinical trials conducted in Ethiopia by the Drugs for Neglected Diseases initiative, in partnership with Médecins Sans Frontières, the University of Gondar, and Addis Ababa University, open the way for more effective and safer treatments for people with both HIV and visceral leishmaniasis, a group of patients who have historically suffered from poor treatment options.

18 Jan 2019

Study looks at trends over time in oral antibiotic prescribing by dermatologists

This study looked at trends over time in oral antibiotic prescribing by dermatologists using commercial insurance claims data for almost 986,000 courses of oral antibiotics prescribed by nearly 12,000 dermatologists.

17 Jan 2019

WTC first responders at higher risk for head and neck cancers, study finds

A Rutgers study has found a significant increase in head and neck cancers among workers and volunteers who responded to the 9/11 terrorist attacks on the World Trade Center (WTC), pointing to newly emerging risks that require ongoing monitoring and treatment of those who were exposed during the initial response.

17 Jan 2019

Clinigen, Accord Healthcare extend exclusive European clinical trial supply agreement

Clinigen Group plc, the global pharmaceutical and services company, announces that its Clinical Trial Service business has extended its exclusive European clinical trial supply agreement with Accord Healthcare. Clinigen is also offering pharma companies an ‘on demand’ service to Accord’s products, a first for the industry.

From Clinigen Group 11 Jan 2019

Researchers examine benefits of oral supplement for patients with thyroid eye disease

Fight for Sight and the Thyroid Eye Disease Charitable Trust are funding research to establish the benefits of using a type of oral supplement for UK patients with thyroid eye disease, which affects around 300,000 people in the UK.

11 Jan 2019

AGA's new clinical guideline to help manage patients with mild-to-moderate ulcerative colitis

Most patients with ulcerative colitis have mild-to-moderate disease characterized by periods of activity or remission, but practice variations exist in disease management.

10 Jan 2019

Oral News and Research

SCYNEXIS announces positive results from first interim efficacy analysis of FURI study

Microbes on the tongue could be used to diagnose pancreatic cancer

New drug for sleeping sickness approved in the Democratic Republic of Congo

OHS pipeline program enhance academic preparedness of students from minority groups

Vaccination with live S. mitis may offer protection from Streptococcus pneumoniae

FDA approves first generic version of commonly prescribed asthma inhaler

POWTECH 2019: Innovations to provide more speed, efficiency in pharmaceutical production

Researchers demonstrate strong evidence connecting bacterial pathogen and Alzheimer's pathogenesisis

Opioid overdose patients can be safely discharged an hour after administration of naloxone

The connection between the Pope and contraceptive pills

Study to investigate new targeted oral treatments for severe asthma

Orthodontic treatment does not guarantee future dental health

Specific cognitive deficits found in individuals with spinal cord injury

ACCC survey finds multiple threats to growth of cancer programs

Combination therapy shows high efficacy in treating people with leishmaniasis and HIV

Study looks at trends over time in oral antibiotic prescribing by dermatologists

WTC first responders at higher risk for head and neck cancers, study finds

Clinigen, Accord Healthcare extend exclusive European clinical trial supply agreement

Researchers examine benefits of oral supplement for patients with thyroid eye disease

AGA's new clinical guideline to help manage patients with mild-to-moderate ulcerative colitis

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News